ASD — Defiance Autism Impact ETF
Data updated: 2026-08-28
ASD — Defiance Autism Impact ETF. Global (incl. US) Small Cap Blend / Core Health Care Equity · $1.35M AUM. Holdings, fees, performance and SEC filings.
ASD Fund Overview
ASD — Defiance Autism Impact ETF is a US ETF managed by ETF Series Solutions, categorised as Global (incl. US) Small Cap Blend / Core Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: ETF Series Solutions
- Category: Global (incl. US) Small Cap Blend / Core Health Care Equity
- Assets under management: $1.35M
- Ticker: ASD
- SEC CIK: 0001540305
- SEC series ID: S000105084
- Share class ID: C000275814
ASD Holdings
Top 10 holdings of Defiance Autism Impact ETF by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| Definium Therapeutics Inc | 4.77% |
| Neuren Pharmaceuticals Ltd | 3.23% |
| LifeStance Health Group Inc | 3.04% |
| Otsuka Holdings Co Ltd | 2.95% |
| Acadia Healthcare Co Inc | 2.90% |
| ACADIA Pharmaceuticals Inc | 2.89% |
| MapLight Therapeutics Inc | 2.89% |
| AbbVie Inc | 2.72% |
| BrightSpring Health Services I | 2.70% |
| Revvity Inc | 2.68% |
ASD Portfolio Allocation
Asset-class allocation of Defiance Autism Impact ETF by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.8% |
| Cash & Equivalents | 0.2% |
ASD Performance
Total returns for ASD (as of 2026-09-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | 8.1% |
ASD Costs and Fees
ASD costs about $79 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.79%
- Gross expense ratio: 0.79%
ASD Cashflows
Over the 12 months to 2026-06, Defiance Autism Impact ETF had net inflows of $1.25M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-06 | $1.25M |
ASD Debt Constituents
No individual debt constituents are reported in Defiance Autism Impact ETF's latest SEC N-PORT filing.
ASD Prospectus and SEC Filings
Official Defiance Autism Impact ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Related funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.